why didn't semaglutide work for me The Pros and Cons of Weight Loss 7 Reasons Why You're Not

10.1016/j.ejphar.2022.175439 16 ChristE.WildD.EdererS.BeheM.NicolasG.CaplinM

[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Qiao Q., Ouwens M.J., Grandy S., Johnsson K., Kostev K

These check-ins allow us to review your progress, address concerns, and adjust your treatment plan

Compared to dual agonists such as Tirzepatide and single-pathway compounds like Semaglutide, Retatrutide represents a broader multi-pathway research model

2 In 2024, the approved commercial versions of semaglutide are Ozempic 3-4 , Rybelsus 3,5 , and Wegovy injection 3,6 , developed by Novo Nordisk

Clinical trials revealed that 2.9% of patients treated with Wegovy, a semaglutide formulation, developed anti-semaglutide antibodies